Digital Content 
NEWS #PharmaBuzz
01 Jun 2020
// ANVISA
http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/hepatite-c-anvisa-alerta-sobre-medicamento-falsificado/219201?p_p_auth=Yai2lXHR&inheritRedirect=false&redirect=http%3A%2F%2Fportal.anvisa.gov.br%2Fnoticias%3Fp_p_auth%3DYai2lXHR%26p_p_id%3D101_INSTANCE_FXrpx9qY7FbU%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3D_118_INSTANCE_KzfwbqagUNdE__column-2%26p_p_col_count%3D2
30 Sep 2019
// B. Hargreaves IN-PHARMATECHNOLOGIST
https://www.in-pharmatechnologist.com/Article/2019/09/30/AbbVie-receives-approval-HCV-treatment
18 Sep 2019
// Samantha Liss BIOSPAHRMADIVE
https://www.biopharmadive.com/news/regulatory-barriers-limit-alternative-state-drug-payment-models/563204/
22 Jan 2019
// Andrew McCg PM LIVE
http://www.pmlive.com/pharma_news/nhs_england_sees_off_abbvies_hep_c_legal_challenge_1275737
08 Jan 2019
// Arlene Weintraub FIERCE PHARMA
https://www.fiercepharma.com/pharma/scotus-declines-to-hear-appeals-from-merck-gilead-two-high-profile-drug-battles
13 Dec 2018
// Beth S Bulik FIERCE PHARMA
https://www.fiercepharma.com/marketing/abbvie-highlights-mavyret-s-8-week-advantage-new-ad-campaign-as-it-continues-its-hep-c
Share 